IP Library Granted Patent US 8,778,399
Granted Patent B2
US 8,778,399 · App. 12/665,499 · Granted Jul 15, 2014

In situ, liquid-activated film coated tablets and a process for making the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,778,399
App. No.
12/665,499
Granted
Jul 15, 2014
Kind
B2
Abstract

Tablets and other objects are film coated by including in the tablet a film-forming polymer that is activated upon contact with an activating amount of liquid. The film-forming polymer, e.g., a cellulosic ether, is homogeneously mixed with the other ingredients of the tablet, shaped into any desirable form, loaded into a conventional coating apparatus, and sprayed or foamed with an activating amount of fluid, e.g., water, alcohol, etc., and dried. This coating process eliminates potential problems such as spray nozzle clogging, inappropriate coating fluid viscosity, and the inability to properly atomize the coating fluid. This coating process does not impart any appreciable weight or thickness gain to the tablet.

Claims (10)

1. A process of making a dosage form product that comprises a core and a film-coating, the process comprising the steps of

preparing a core from a pharmaceutically active ingredient and a material comprising a water-soluble, film-forming polymer with a weight average molecular weight of at least 12,000, wherein the film-forming polymer is a cellulose ester or a cellulose ether,

compressing the core into a desired size and shape, and

then coating the core by activating the film-forming polymer in the core by contacting the core with a sufficient amount of liquid activating fluid containing a surface tension lowering agent and at least 90 percent by weight water to hydrate the film-forming polymer into a film coating on the core,

wherein no film-forming polymer is contained in the activating fluid, and wherein the core and film coating each have a chemical composition that is essentially the same as the other.

2. The process of claim 1 in which the film-forming polymer is a cellulose ether.

3. The process of claim 1 in which the film-forming polymer is homogeneously dispersed throughout the dosage form product.

4. The process of claim 1 in which the film forming polymer is methyl cellulose.

5. The process of claim 1 in which the film forming polymer is hydroxypropyl methylcellulose.

6. The process of claim 1 in which the surface tension lowering agent is sodium lauryl sulfate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2014
From: SHESKEY, PAUL J.; KEARY, COLIN M.
To: DOW GLOBAL TECHNOLOGIES LLC
Reel/Frame 032714/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2014
From: SHESKEY, PAUL J; KEARY, COLIN M
To: DOW GLOBAL TECHNOLOGIES INC.
Reel/Frame 032651/0981 →
CHANGE OF NAME Recorded Apr 6, 2011
From: DOW GLOBAL TECHNOLOGIES INC.
To: DOW GLOBAL TECHNOLOGIES LLC
Reel/Frame 026082/0249 →